India Hosts 2nd Global Drug Policymakers’ Forum
The 2nd Policymakers’ Forum was recently inaugurated in India, fostering a platform for regulatory collaboration and affordable healthcare access among 24 participating countries. The Union Minister of State for Health and Family Welfare, Anupriya Patel, officially launched the event, which aimed to promote Indian Pharmacopoeia and the Jan Aushadhi scheme.
The event brought together esteemed delegates from around the world to discuss pressing issues in the pharmaceutical industry and explore opportunities for cooperation. As India continues to assert its leadership in the global healthcare landscape, the forum provided a crucial platform for policymakers, industry experts, and healthcare professionals to share knowledge, best practices, and innovative solutions.
India’s Commitment to “Health for All”
In her inaugural address, Minister Patel emphasized India’s commitment to achieving the United Nations’ Sustainable Development Goal (SDG) 3, “Health for All.” She highlighted India’s significant progress in the healthcare sector, particularly in the areas of vaccine development, generics, and drug standards. Patel acknowledged the country’s challenges, but stressed its determination to address them and ensure accessible and affordable healthcare for all citizens.
India’s pharmaceutical industry has gained recognition globally for its high-quality generic medicines and vaccines. The country has been at the forefront of vaccine development, with several indigenous vaccines approved for use in the country. The Jan Aushadhi scheme, launched in 2008, has successfully made affordable generic medicines available to millions of Indians, significantly reducing out-of-pocket expenses and improving healthcare outcomes.
Promoting Regulatory Collaboration
The Policymakers’ Forum aimed to promote regulatory collaboration among participating countries, enabling the sharing of best practices and experiences in drug regulation, quality control, and standards. Delegates discussed topics such as:
- Good Manufacturing Practices (GMP) and Good Clinical Practices (GCP)
- Pharmacovigilance and adverse event reporting
- Regulatory frameworks for medical devices and pharmaceuticals
- Strategies for improving access to affordable medicines
The event also provided a platform for countries to share their approaches to addressing common challenges, such as counterfeit medicines, drug shortages, and antibiotic resistance.
India’s Contribution to Global Healthcare
India’s pharmaceutical industry has made significant contributions to global healthcare, particularly in the areas of vaccine development and production. The country has played a crucial role in the global fight against diseases such as malaria, tuberculosis, and COVID-19. India’s vaccine manufacturers have been instrumental in producing vaccines for various diseases, including HPV, Hepatitis B, and influenza.
The country’s generics industry has also made a significant impact on global healthcare, providing affordable alternatives to branded medicines. India’s generics industry has enabled millions of people around the world to access essential medicines, improving healthcare outcomes and reducing healthcare expenditure.
Conclusion
The 2nd Policymakers’ Forum was a significant event in the global healthcare calendar, bringing together stakeholders from around the world to promote regulatory collaboration and affordable healthcare access. India’s commitment to “Health for All” and its leadership in vaccine development, generics, and drug standards were reaffirmed through the event. As the country continues to assert its global leadership in the healthcare sector, the Policymakers’ Forum will play a crucial role in shaping the future of healthcare policy and practice.
Source:
https://www.refersms.com/india-hosts-2nd-global-drug-policy/
